Results 301 to 310 of about 151,232 (337)

von Willebrand Disease

Hematology/Oncology Clinics of North America, 1990
The study of a wide variety of patients with vWD disorders has been extensive and intense over the last decade. In many instances the peculiarities of the expressions of the disorder have been critical in defining the underlying structure and function of vWF itself.
openaire   +2 more sources

von Willebrand Disease and Pregnancy

Journal of Maternal-Fetal and Neonatal Medicine, 2000
von Willebrand Disease (vWD) affects approximately 1% of Americans and as many as 25% of women referred for evaluation of menorrhagia. We briefly review the history of vWD, its molecular defects, and diagnostic criteria for each subtype of disease. We also address obstetric management of the patient with vWD. While there is a significant increased risk
H, Roqué, E, Funai, C J, Lockwood
openaire   +2 more sources

Von Willebrand's disease

Postgraduate Medicine, 1980
Von Willebrand's disease is an autosomally transmitted disorder of hemostasis caused by a deficiency of or defect in the von Willebrand factor in the blood, a protein required for adherence of platelets to an injured vessel wall. The disease's principal manifestations are spontaneous bleeding from mucous membranes, excessive bleeding from wounds, and ...
openaire   +2 more sources

Von Willebrand's disease: clinical management

Haemophilia, 2006
Summary.  The aim of treatment of von Willebrand's disease (VWD) is to correct the dual defect of haemostasis, i.e. the abnormal platelet adhesion due to reduced and/or dysfunctional von Willebrand factor (VWF) and the abnormal coagulation expressed by low levels of factor VIII (FVIII).
A.B. Federici, G. Castaman, A. Thompson, E. Berntorp   +3 more
openaire   +2 more sources

Diagnosis of von Willebrand Disease

Haemophilia, 1999
The haemorrhagic diathesis in von Willebrand disease (vWD) is caused by a quantitative deficiency or a qualitative defect in the von Willebrand factor (vWF) in plasma and/or platelets causing insufficient primary haemostasis. Since vWF binds and protects factor VIII (FVIII) towards random proteolysis, coagulation may also be impaired in patients with a
Ingerslev, J, Gursel, T
openaire   +3 more sources

Pseudo-von Willebrand's Disease

New England Journal of Medicine, 1982
It is now recognized that von Willebrand's disease, a disorder characterized by a long bleeding time and reduced factor VIII, is a frequent cause of a mild hemorrhagic diathesis.1 Recent studies of...
openaire   +2 more sources

Acquired Von Willebrand's Disease

Hematology/Oncology Clinics of North America, 1992
avWD is a rare entity that is primarily associated with lymphoproliferative disorders, most commonly with multiple myeloma, lymphoma, and the myeloproliferative diseases. Various pathogenetic mechanisms have been postulated. The most commonly seen is antibodies directed against the FVIII complex, resulting in either its accelerated destruction or its ...
openaire   +2 more sources

Acquired von Willebrand disease

Haemophilia, 1999
Acquired von Willebrand disease (AvWD) is a syndrome that has clinical and laboratory features similar to hereditary vWD. In contrast to the latter it occurs in patients without a family history of previous bleeding tendency.
openaire   +2 more sources

Treatment of von Willebrand's disease

Journal of Internal Medicine, 1997
von Willebrand's disease is the most frequent of inherited bleeding disorders (1:100 affected individuals in the general population). The aim of therapy is to correct the dual defects of haemostasis, i.e. abnormal coagulation expressed by low levels of factor VIII and abnormal platelet adhesion expressed by a prolonged bleeding time. There are two main
openaire   +3 more sources

Von Willebrand's Disease

Clinics in Haematology, 1983
T S, Zimmerman, Z M, Ruggeri
openaire   +3 more sources